International Research Journal of Engineering and Technology (IRJET) Volume: 13 Issue: 09 | Sep 2026
www.irjet.net
e-ISSN: 2395-0056 p-ISSN: 2395-0072
Chitosan–GrapheneOxide Nanocomposites for Biomedical Engineering: Recent Advances in Bone, Wound, and Neural Regeneration J. R. González-Martínez¹, R. Gámez-Corrales², F. Barffuson-Domínguez3 ¹ Departamento de Investigación en Física, Universidad de Sonora, Apdo. Postal 1626, 83000 Hermosillo, Sonora, México 23 Departamento de Física, Universidad de Sonora, Apdo. Postal 1626, 83000 Hermosillo, Sonora, México. ---------------------------------------------------------------------***---------------------------------------------------------------------
Abstract - Chitosan (CS) and graphene oxide (GO) form
for its structural biocompatibility, enzymatic biodegradability, cationic nature, intrinsic hemostatic capacity, and broad-spectrum antimicrobial activity [1]. These inherent biological attributes render CS an attractive candidate for tissue engineering scaffolds, topical wound dressings, and in situ gelating systems [5– 7].
multifunctional nanocomposites that unite CS’s biocompatibility, hemostatic capacity, and antimicrobial activity with GO’s high surface area, mechanical reinforcement, and tunable interfacial chemistry. This narrative review synthesizes recent advances in CS–GO systems for bone, wound, and neural regeneration, emphasizing structure–property–function relationships, fabrication strategies, and biological performance. In bone tissue engineering, CS–GO scaffolds and injectable hydrogels enhance osteogenic differentiation, mineralization, and mechanical integrity, supported by emerging in vivo evidence from rodent critical-size defect models. For wound care, CS–GO films, nanofibers, and hydrogels provide antibacterial, hemostatic, and pro-angiogenic functions, including in diabetic and infected models, although clinical translation remains at an early stage. In neural regeneration, conductive and topographically aligned GOcontaining constructs improve Schwann cell behavior and neurite outgrowth; however, direct CS–GO in vivo evidence is still limited compared to GO-only or CS-only systems. Cross-cutting challenges include inconsistent reporting of CS degree of deacetylation and molecular weight, heterogeneous GO physicochemical characterization, dosedependent cytotoxicity concerns, and scarce long-term in vivo biodistribution and degradation data. We conclude that CS–GO nanocomposites represent a promising platform for regenerative medicine, but standardized reporting, rigorous biosafety evaluation, scalable manufacturing, and validation against clinically relevant endpoints are essential before widespread translational adoption.
However, pristine chitosan matrices frequently suffer from mechanical fragility in hydrated states, uncontrolled swelling, and rapid enzymatic degradation, which can compromise structural support during tissue repair. To overcome these limitations, graphene oxide (GO) a twodimensional carbon nanomaterial rich in oxygenated functional groups (epoxides, hydroxyls, carboxyls) has emerged as an exceptional nano-reinforcement and functional additive [1–3]. GO possesses extraordinary mechanical strength, high specific surface area, and versatile surface chemistry that facilitates biomolecule adsorption, cellular engagement, and interfacial crosslinking [3, 4]. Integrating CS and GO generates highly synergistic nanocomposite architectures [1]. Hydrophilic CS matrices facilitate the uniform dispersion of GO nanosheets via electrostatic and hydrogen-bonding interactions, mitigating GO's propensity to aggregate and reducing potential dose-dependent cytotoxicity [1][8–9]. Conversely, GO reinforces CS networks, enhancing tensile and compressive moduli, tailoring swelling and degradation kinetics, and imparting electroactive and bioactive characteristics [2–4–10]. This review critically examines CS-GO nanocomposites encompassing hydrogels, electrospun nanofibrous mats, porous scaffolds, dense membranes, and injectable platforms—focusing on three major biomedical engineering domains:bone tissue engineering, wound healing, and peripheral neural regeneration.
Key Words: chitosan, graphene oxide, nano composites, bone tissue engineering, neural regeneration, regenerative medicine
1. INTRODUCTION The global burden of traumatic injury, chronic non-healing wounds, and degenerative musculoskeletal and neurological conditions continues to drive demand for advanced regenerative biomaterials capable of actively directing cell behavior, resisting infection, and integrating seamlessly with host tissue[1–4]. Among natural and synthetic polymers, chitosan (CS) a linear polysaccharide obtained by the partial deacetylation of chitin stands out
© 2026, IRJET
|
Impact Factor value: 8.315
2. Materials Science Foundations of Chitosan– Graphene Oxide Nanocomposites 2.1 Chitosan: Molecular Biomedical Relevance
Characteristics
and
Chitosan is composed of randomly distributed β-(1→4)linked D-glucosamine and N-acetyl-D-glucosamine units[1]
|
ISO 9001:2008 Certified Journal
|
Page 129
International Research Journal of Engineering and Technology (IRJET) Volume: 13 Issue: 09 | Sep 2026
www.irjet.net
e-ISSN: 2395-0056 p-ISSN: 2395-0072
[11–12]. Its chemical functionality and biological behavior are dictated by its degree of deacetylation (DD) and molecular weight (MW) [11][13]. High DD (>80%) provides a higher density of primary amino groups (-NH₂), which become protonated (-NH₃⁺) under acidic conditions, conferring solubility and strong electrostatic affinity for anionic biomolecules, cell membranes, and negatively charged GO nanosheets [1,12]. High MW enhances mechanical stability and film-forming ability but increases solution viscosity, whereas low MW improves aqueous solubility and cellular uptake [11,13]. 2.2 Graphene Oxide: Structure, Physicochemical Properties, and Biological Considerations
Figure 1. CS-GO chemical interactions and fabrication. (A) Hydrogen bonding and electrostatic coupling between CS and GO. (B) Synthesis routes: freeze-drying, electrospinning, and 3D printing.
GO features an sp² carbon network interspersed with sp³ domains bearing hydroxyl (-OH) and epoxide (-O-) groups on basal planes, alongside carboxyl (-COOH) groups at sheet edges [1, 3, [14]. Lateral dimension, layer number, C/O ratio, and synthesis-derived impurity content (e.g., residual heavy metals) dictate GO's mechanical performance, dispersibility, cellular toxicity, and cellular endocytosis pathways [3, 8, 14]. At controlled, low concentrations (≤1 wt%), GO enhances cellular adhesion and proliferation through protein adsorption, but high concentrations can induce reactive oxygen species (ROS) generation and cell membrane shear stress [8, 9, 14].
3. Bone Regeneration and Bone Tissue Engineering Bone tissue engineering requires scaffolds that provide structural integrity matching host trabecular or cortical bone, highly interconnected porosity (100-300 µm) for vascular ingrowth, osteoconductivity, and osteoinductivity [2-4, 15]. CS-GO nanocomposites fulfill these criteria by serving as biomimetic templates that stimulate osteogenic differentiation and biomineralization [2, 5]. Incorporation of GO (typically 0.5-2 wt%) into CS scaffolds markedly elevates compressive strength and Young's modulus, counteracting the structural collapse often observed in pure CS hydrogels [2, 5]. Furthermore, GO acts as a nucleation site for hydroxyapatite (Ca₁₀(PO₄)₆(OH)₂) deposition by concentrating calcium ions through its oxygenated functional groups [3, 4]. In vitro studies confirm up-regulated expression of key osteogenic markers, including alkaline phosphatase (ALP), Runtrelated transcription factor 2 (Runx2), and osteocalcin (OCN) in mesenchymal stem cells (MSCs) and osteoblasts cultured on CS-GO platforms [2, 5].
2.3 Interfacial Interactions and Nanocomposite Design The synthesis of robust CS-GO nanocomposites relies on strong interfacial non-covalent interactions, predominantly hydrogen bonding between hydroxyl/amino groups of CS and oxygenated moieties of GO, alongside electrostatic attraction between cationic -NH₃⁺ and anionic carboxylates [1]. Covalent crosslinking via genipin, glutaraldehyde, or oxidized polysaccharides further stabilizes the network [2, 6, 10]. Common fabrication techniques include: (i) solvent casting and freeze-drying for 3D macroporous scaffolds; (ii) electrospinning for extracellular matrix (ECM)mimicking nanofibers; (iii) 3D bioprinting for custom geometries; and (iv) in situ gelation for injectable, minimally invasive hydrogels [1, 5].
In vivo preclinical evaluation in rodent critical-size calvarial and femoral defect models demonstrates that injectable CS-GO hydrogels (e.g., glycol CS / oxidized hyaluronic acid + GO) accelerate bone healing, promoting osteogenesis and robust neo-vascularization without systemic toxicity [6]. Hybrid systems incorporating biomimetic minerals (CS-GO-HA) further bridge mechanical durability and osteoinduction [4, [9].
4. Wound Regeneration and Advanced Wound Dressings Chronic, non-healing wounds particularly diabetic ulcers are characterized by prolonged inflammation, excessive oxidative stress, high bacterial burden, and impaired angiogenesis [7,10,16, 17]. CS-GO dressings address these
© 2026, IRJET
|
Impact Factor value: 8.315
|
ISO 9001:2008 Certified Journal
|
Page 130
International Research Journal of Engineering and Technology (IRJET) Volume: 13 Issue: 09 | Sep 2026
www.irjet.net
e-ISSN: 2395-0056 p-ISSN: 2395-0072
complex pathological microenvironments through synergistic antimicrobial, anti-inflammatory, and exudatemanaging mechanisms [7, 8].
elongation, S100β and myelin basic protein (MBP) expression, and dorsal root ganglion (DRG) neurite outgrowth in vitro [18, 20].
Chitosan's intrinsic antibacterial activity, driven by membrane lysis via protonated amines, is supplemented by GO's physical sharp-edge membrane truncation, ROSmediated oxidative stress, and photothermal disruption under near-infrared (NIR) laser irradiation [1, 7, 8]. CS-GO nanofibrous mats and hydrogels exhibit potent bactericidal efficiency against Gram-positive (e.g., Staphylococcus aureus) and Gram-negative (e.g., Escherichia coli) pathogens, including multidrug-resistant strains [7, 10]. Additionally, CS-GO platforms serve as versatile drug delivery vectors for antibiotics, growth factors (e.g., VEGF, bFGF), and natural bioactive compounds (e.g., curcumin, quercetin) [15, 16]. In diabetic full-thickness wound models, CS-GO hydrogels accelerate re-epithelialization, enhance granulation tissue maturation, promote angiogenesis, and reduce pro-inflammatory cytokines (TNF-α, IL-6) [10, 17].
6. Biocompatibility, Biosafety, and Translational Barriers Despite compelling preclinical efficacy, the translational trajectory of CS-GO nanocomposites from bench to bedside faces several technical and regulatory obstacles [1, 8, 13, 14]: Dose-Dependent Cytotoxicity: GO concentrations exceeding 1.0-2.0 wt% can induce membrane rupture, ROS overload, and apoptosis. CS coating shields cellular membranes, but precise safety thresholds must be defined [1, 8]. Long-term Biodegradation & Biodistribution: While CS degrades via lysozyme, the long-term metabolic fate, degradation kinetics, and clearance routes of nonbiodegradable GO sheets in vivo remain poorly understood [8, 14]. Physicochemical Heterogeneity: Substantial inter-study variability in CS molecular weight/DD and GO lateral size, oxidation level (C/O ratio), and purity hinders reproducibility and standardized manufacturing under GMP conditions [1, 13]. Lack of Clinical Trials: Current evidence remains strictly preclinical; no standardized human clinical trials have yet been completed for CS-GO regenerative devices [1].
Figure 2. Biomedical applications of CS-GO nanocomposites. Targeted mechanisms in bone regeneration (mineralization), wound healing (antibacterial/angiogenesis), and neural conduits (aligned bioelectricity).
5. Neural Interfaces
Regeneration
and
Bioelectronic
Peripheral nerve injury repair demands bio-instructive conduits that combine topographical alignment, mechanical flexibility, and electrical conductivity to guide axonal elongation and support Schwann cell (SC) proliferation 18–21]. While pristine CS offers good biocompatibility and tubular guidance, its lack of electrical conductivity limits active bioelectric signal propagation [19,21].
Figure 3. Translational pipeline for CS-GO biomaterials. Sequential stages from material synthesis and ISO 10993 testing to preclinical models, GMP scale-up, and regulatory approval.
7. CURRENT KNOWLEDGE GAPS AND FUTURE PRIORITIES
Incorporation of GO into aligned CS electrospun nanofibers or extruded guidance conduits yields electroactive substrates (electrical conductivity ~10⁻² S/cm) [18, 20]. Aligned CS-GO constructs provide both contact guidance and passive bioelectric coupling, significantly enhancing SC
© 2026, IRJET
|
Impact Factor value: 8.315
To overcome translational barriers, future research must prioritize: (i) standardized reporting of CS DD/MW and GO lateral dimensions/purity; (ii) ISO 10993-compliant
|
ISO 9001:2008 Certified Journal
|
Page 131
International Research Journal of Engineering and Technology (IRJET) Volume: 13 Issue: 09 | Sep 2026
www.irjet.net
biocompatibility and hemocompatibility testing; (iii) longterm fate and clearance studies in large animal models; (iv) integration of electrical stimulation paradigms in neural constructs; and (v) head-to-head benchmarking against established clinical standards (e.g., autografts, commercial collagen dressings) [1, 9, 15, 22].
Faghihi, Graphene oxide incorporated polycaprolactone/chitosan/collagen electrospun scaffold: Enhanced osteogenic properties for bone tissue engineering. Artificial organs, 43 (2019) E264–E281. https://doi.org/10.1111/AOR.13474. 6) S. J. Lee, H. Nah, D. N. Heo, K. H. Kim, J. M. Seok, M. Heo, H. J. Moon, D. Lee, J. S. Lee, S. Y. An, Y. S. Hwang, W. K. Ko, S. J. Kim, S. Sohn, S. A. Park, S. Y. Park, & I. K. Kwon, Induction of osteogenic differentiation in a rat calvarial bone defect model using an In situ forming graphene oxide incorporated glycol chitosan/oxidized hyaluronic acid injectable hydrogel. Carbon, 168 (2020) 264– 277. https://doi.org/10.1016/J.CARBON.2020.05.022.
8. CONCLUSIONS Chitosan-graphene oxide (CS-GO) nanocomposites represent a versatile, multifunctional material platform for regenerative medicine. By unifying the intrinsic bioactivity, hemostatic capability, and antimicrobial properties of chitosan with the mechanical strength, high surface area, and electroactive capabilities of graphene oxide, CS-GO systems demonstrate outstanding performance in bone, wound, and neural tissue repair. Continued focus on standardized synthesis, scalable GMP fabrication, longterm biosafety, and rigorous clinical validation will be key to unlocking their full translational potential.
7) S. Li, J. Wang, H. Zhang, & X. Zhang, Advances in graphene oxide-based polymeric wound dressings for wound healing. Frontiers in Materials, 12 (2025). https://doi.org/10.3389/FMATS.2025.1635502/ FULL.
REFERENCES
8) L. Xuan, Z. Ju, M. Skonieczna, P. K. Zhou, & R. Huang, Nanoparticles‐induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation models. MedComm, 4 (2023) e327. https://doi.org/10.1002/MCO2.327.
1) W. Feng & Z. Wang, Biomedical applications of chitosan-graphene oxide nanocomposites. iScience, 25 (2022) 103629. https://doi.org/10.1016/J.ISCI.2021.103629. 2) E. S. Motiee, S. Karbasi, E. Bidram, & M. Sheikholeslam, Investigation of physical, mechanical and biological properties of polyhydroxybutyrate-chitosan/graphene oxide nanocomposite scaffolds for bone tissue engineering applications. International Journal of Biological Macromolecules, 247 (2023) 125593. https://doi.org/10.1016/J.IJBIOMAC.2023.12559 3.
9) A. Shafiee, S. Iravani, & R. S. Varma, Graphene and graphene oxide with anticancer applications: Challenges and future perspectives. MedComm, 3 (2022) e118. https://doi.org/10.1002/MCO2.118. 10) N. Li, Q. Ma, L. Xu, Y. Wang, L. Zhang, Y. Jiang, & H. Liu, Polydopamine reduced graphene oxide/ chitosan-based hydrogel for the therapy of diabetic wound. Materials Today Communications, 39 (2024) 109319. https://doi.org/10.1016/J.MTCOMM.2024.10931 9.
3) J. I. ; Castro, A. ; Payan-Valero, C.-H. ValenciaLlano, V. Zapata, M. E. ; Mina Hernández, J. H. ; Zapata, P. A. ; Grande-Tovar, L. Baia, K. Magyari, J. Won, M. Seo, J. I. Castro, A. Payan-Valero, C.-H. Valencia-Llano, M. Eliana, J. Herminsul, M. Hernández, P. A. Zapata, C. David Grande-Tovar, & J. H. M. H. Co, Citation: molecules Graphene Oxide Nanosheets for Bone Tissue Regeneration. (2024). https://doi.org/10.3390/molecules29143263.
11) M. H. Rahman & M. I. H. Mondal, Stability, challenges, and prospects of chitosan for the delivery of anticancer drugs and tissue regenerative growth factors. Heliyon, 10 (2024) e39879. https://doi.org/10.1016/J.HELIYON.2024.E39879 .
4) X. Li, A. H. Hirad, A. A. Alarfaj, H. Li, R. Santhanam, X. Li, A. H. Hirad, A. A. Alarfaj, H. Li, & R. Santhanam, A convergent fabrication of graphene oxide/silk fibroin/hydroxyapatite nanocomposites delivery improved early osteoblast cell adhesion and bone regeneration. Arabian Journal of Chemistry, 17 (2024) 105468. https://doi.org/10.1016/J.ARABJC.2023.105468.
12) M. A. S. Abourehab, S. Pramanik, M. A. Abdelgawad, B. M. Abualsoud, A. Kadi, M. J. Ansari, & A. Deepak, Recent Advances of Chitosan Formulations in Biomedical Applications. International Journal of Molecular Sciences 2022, Vol. 23, Page 10975, 23 (2022) 10975. https://doi.org/10.3390/IJMS231810975. 13) M. Ul-Islam, K. F. Alabbosh, S. Manan, S. Khan, F. Ahmad, & M. W. Ullah, Chitosan-based nanostructured biomaterials: Synthesis,
5) A. Aidun, A. Safaei Firoozabady, M. Moharrami, A. Ahmadi, N. Haghighipour, S. Bonakdar, & S.
© 2026, IRJET
|
Impact Factor value: 8.315
e-ISSN: 2395-0056 p-ISSN: 2395-0072
|
ISO 9001:2008 Certified Journal
|
Page 132
International Research Journal of Engineering and Technology (IRJET) Volume: 13 Issue: 09 | Sep 2026
www.irjet.net
properties, and biomedical applications. Advanced Industrial and Engineering Polymer Research, 7 (2024) 79–99. https://doi.org/10.1016/J.AIEPR.2023.07.002.
e-ISSN: 2395-0056 p-ISSN: 2395-0072
https://doi.org/10.3389/FCHEM.2024.1417763/ TEXT. 22) D. Chicea & A. Nicolae-Maranciuc, A Review of Chitosan-Based Materials for Biomedical, Food, and Water Treatment Applications. Materials 2024, Vol. 17, Page 5770, 17 (2024) 5770. https://doi.org/10.3390/MA17235770.
14) Y. Hou, C. Zhu, Z. Shen, Y. Xu, S. Zhou, & X. Zhou, Carbon Nanomaterials in Biomedicine: Opportunities and Toxicological Concerns. International Journal of Nanomedicine, 20 (2025) 14707–14730. https://doi.org/10.2147/IJN.S552319. 15) A. M. Narváez-Romero, F. J. Rodríguez-Lozano, & M. P. Pecci-Lloret, Graphene-Based Materials for Bone Regeneration in Dentistry: A Systematic Review of In Vitro Applications and Material Comparisons. Nanomaterials 2025, Vol. 15, Page 88, 15 (2025) 88. https://doi.org/10.3390/NANO15020088. 16) T. ; Lu, X. ; Zhou, S.-Y. ; Jiang, Q.-A. ; Zhao, Z.-Y. ; Liu, D.-F. Ding, T. Lu, X. Zhou, S.-Y. Jiang, Q.-A. Zhao, Z.Y. Liu, & D.-F. Ding, Natural Bioactive CompoundIntegrated Nanomaterials for Diabetic Wound Healing: Synergistic Effects, Multifunctional Designs, and Challenges. Molecules 2025, Vol. 30, Page 2562, 30 (2025) 2562. https://doi.org/10.3390/MOLECULES30122562. 17) S. G. Jin, Recent Applications of Chitosan-Based Biomaterials as Wound Dressings. International Journal of Molecular Sciences 2026, Vol. 27, Page 1637, 27 (2026) 1637. https://doi.org/10.3390/IJMS27041637. 18) X. Zhou, A. Tang, C. Xiong, G. Zhang, L. Huang, & F. Xu, Oriented Graphene Oxide Scaffold Promotes Nerve Regeneration in vitro and in vivo. International Journal of Nanomedicine, 19 (2024) 2573–2589. https://doi.org/10.2147/IJN.S439656. 19) H. Gao, H. Shen, X. Zhang, Y. Liu, Y. Shang, S. Sun, W. Guan, X. Gu, Y. Yang, & G. Li, Revolutionizing neural regeneration with smart responsive materials: Current insights and future prospects. Bioactive Materials, 52 (2025) 393–421. https://doi.org/10.1016/J.BIOACTMAT.2025.06.0 03. 20) K. Yang, S. Yang, X. Teng, X. He, T. Sun, & H. Chen, Modulating Schwann cell behavior via functional nerve guidance conduits for enhanced peripheral nerve regeneration. npj Regenerative Medicine 2025 10:1, 10 (2025) 54-. https://doi.org/10.1038/s41536-025-00443-w. 21) J. Sun, L. He, Q. An, X. Ye, J. Ma, J. Yan, X. Xie, X. Sun, Y. Niu, & W. Cao, Graphene/ chitosan tubes inoculated with dental pulp stem cells promotes repair of facial nerve injury. Frontiers in Chemistry, 12 (2024) 1417763.
© 2026, IRJET
|
Impact Factor value: 8.315
|
ISO 9001:2008 Certified Journal
|
Page 133